Actual Medicinal Product (AMP) Lynlor 5mg capsules (Accord-UK Ltd)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from moisture. Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products OxyNorm 5mg capsules (Napp Pharmaceuticals Ltd) and Shortec 5mg capsules (Qdem Pharmaceuticals Ltd).

Generic
Oxycodone
Formulation
Oxycodone 5mg capsules
  • Oxycodone
    • Oxycodone 5mg capsules

      • Lynlor 5mg capsules (Accord-UK Ltd)